Webinar: Sponsors & CROs Explore CRO Consolidation

Contact Veristat Now


Request A Proposal

Contact Us

March 6, 2018

Veristat recently participated in the webinar titled "CRO Consolidation: A Sinister Threat or Windfall for Pharma?"   View a recording of the webcast now.

View Webinar 

 

With all the recent CRO mergers & acquisitions, a panel of CROs, Sponsors and Patient Advocates discuss the trend and its effects on clinical trial outsourcing.   Outsourcing has become a popular way for pharmaceutical companies to utilize on-demand services, improving operational efficiencies and therapeutic expertise and adding extensive geographic capabilities.  CROs are growing and acquiring new services and offering to differentiate themselves.   So, is this CRO M&A trend good for the pharmaceutical industry as a whole?

Webinar Details

In this webinar, a panel of experts representing CROs, Pharma and Patient Advocates will explore the following:

  • Recent noteworthy mergers and acquisitions (M&As) in the CRO industry and related eClinical technology providers
  • Benefits for sponsors the M&A trend in the CRO industry provides
  • Drawbacks to consider for sponsors in the M&A trend of CROs and related eClinical technology providers
  • The ramifications of CRO consolidation in study startup, a notorious bottleneck in starting clinical trials and changing role of sponsors in oversight/transparency of operations

Email Headshot_Cindy Henderson.pngDon't miss your chance to hear Cindy Henderson, Executive Vice President of Strategic Development at Veristat join the conversation in this webinar.

How To View A Recording of the  Webinar:

 Click Here to sign in and view a recording of the webinar.